Skip to main content
Top
Published in: Annals of Surgical Oncology 4/2014

01-04-2014 | Breast Oncology

Risk Factors Associated with Breast Lymphedema

Authors: Judy C. Boughey, MD, Tanya L. Hoskin, MS, Andrea L. Cheville, MD, Joyce Miller, RN, Margie D. Loprinzi, RN, Kristine M. Thomsen, BS, Shaun Maloney, BA, Larry M. Baddour, MD, Amy C. Degnim, MD

Published in: Annals of Surgical Oncology | Issue 4/2014

Login to get access

Abstract

Background

The development of breast lymphedema (BLE) after breast/axillary surgery is poorly characterized. We prospectively evaluated clinical and surgical factors associated with development of BLE.

Methods

Patients undergoing unilateral breast-conserving surgery were prospectively enrolled preoperatively and followed for development of BLE. To augment the number of patients with BLE for evaluation of risk factors, postoperative patients identified in the clinic with signs and symptoms of BLE were also enrolled. Logistic regression with Firth’s penalized likelihood bias-reduction method was used for univariate and multivariate analysis.

Results

Of 144 women, 124 were enrolled preoperatively (38 of whom developed BLE), and 20 women with BLE were enrolled postoperatively. Any type of axillary surgery was the strongest factor associated with BLE (odds ratio, 134; 95 % confidence interval, 18 to >1,000). All 58 BLE events occurred in women with axillary surgery as compared with no events in the 46 patients without axillary surgery (p < 0.0001). Among 98 women who underwent axillary surgery, BLE did not occur more often after axillary lymph node dissection versus sentinel lymph node biopsy (p = 0.38) and was not associated with total number of nodes removed (p = 0.52). In multivariate analysis, factors associated with the development of BLE in the axillary surgery subgroup included baseline BMI (p = 0.004), incision location (p = 0.009), and prior surgical biopsy (p = 0.01).

Conclusions

Risk of BLE is primarily related to performance of any axillary surgery but not the extent of axillary surgery or number of lymph nodes removed. Other factors associated with BLE were increased body mass index, incision location, and prior surgical excisional biopsy.
Literature
1.
go back to reference Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001;92:1368–77.PubMedCrossRef Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001;92:1368–77.PubMedCrossRef
2.
go back to reference Clarke D, Martinez A, Cox RS, Goffinet DR. Breast edema following staging axillary node dissection in patients with breast carcinoma treated by radical radiotherapy. Cancer. 1982;49:2295–2299.PubMedCrossRef Clarke D, Martinez A, Cox RS, Goffinet DR. Breast edema following staging axillary node dissection in patients with breast carcinoma treated by radical radiotherapy. Cancer. 1982;49:2295–2299.PubMedCrossRef
3.
go back to reference Ronka RH, Pamilo MS, von Smitten KA, Leidenius MH. Breast lymphedema after breast conserving treatment. Acta Oncol. 2004;43:551–557.PubMedCrossRef Ronka RH, Pamilo MS, von Smitten KA, Leidenius MH. Breast lymphedema after breast conserving treatment. Acta Oncol. 2004;43:551–557.PubMedCrossRef
4.
go back to reference Degnim AC, Miller J, Hoskin TL, et al. A prospective study of breast lymphedema: frequency, symptoms, and quality of life. Breast Cancer Res Treat. 2012;134:915–922.PubMedCentralPubMedCrossRef Degnim AC, Miller J, Hoskin TL, et al. A prospective study of breast lymphedema: frequency, symptoms, and quality of life. Breast Cancer Res Treat. 2012;134:915–922.PubMedCentralPubMedCrossRef
5.
go back to reference Firth D. Bias reduction of maximum likelihood estimates. Biometrika. 1993;80:27–38.CrossRef Firth D. Bias reduction of maximum likelihood estimates. Biometrika. 1993;80:27–38.CrossRef
7.
go back to reference Loprinzi CL, Okuno S, Pisansky TM, Sterioff S, Gaffey TA, Morton RF. Postsurgical changes of the breast that mimic inflammatory breast carcinoma. Mayo Clinic Proc. 1996;71:552–555.CrossRef Loprinzi CL, Okuno S, Pisansky TM, Sterioff S, Gaffey TA, Morton RF. Postsurgical changes of the breast that mimic inflammatory breast carcinoma. Mayo Clinic Proc. 1996;71:552–555.CrossRef
8.
go back to reference Staren ED, Klepac S, Smith AP, et al. The dilemma of delayed cellulitis after breast conservation therapy. Arch Surg. 1996;131:651–654.PubMedCrossRef Staren ED, Klepac S, Smith AP, et al. The dilemma of delayed cellulitis after breast conservation therapy. Arch Surg. 1996;131:651–654.PubMedCrossRef
9.
go back to reference Baddour LM. Breast cellulitis complicating breast conservation therapy. J Intern Med. 1999;245:5–9.PubMedCrossRef Baddour LM. Breast cellulitis complicating breast conservation therapy. J Intern Med. 1999;245:5–9.PubMedCrossRef
10.
go back to reference Silverstein MJ, Recht A, Lagios MD, et al. Special report: consensus conference III—image-detected breast cancer. State-of-the-art diagnosis and treatment. J Am Coll Surg. 2009;209:504–520.PubMedCrossRef Silverstein MJ, Recht A, Lagios MD, et al. Special report: consensus conference III—image-detected breast cancer. State-of-the-art diagnosis and treatment. J Am Coll Surg. 2009;209:504–520.PubMedCrossRef
11.
go back to reference White RR, Halperin TJ, Olson JA Jr, Soo MS, Bentley RC, Seigler HF. Impact of core-needle breast biopsy on the surgical management of mammographic abnormalities. Ann Surg. 2001;233:769–777.PubMedCentralPubMedCrossRef White RR, Halperin TJ, Olson JA Jr, Soo MS, Bentley RC, Seigler HF. Impact of core-needle breast biopsy on the surgical management of mammographic abnormalities. Ann Surg. 2001;233:769–777.PubMedCentralPubMedCrossRef
13.
go back to reference McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008;26:5213–5219.PubMedCentralPubMedCrossRef McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008;26:5213–5219.PubMedCentralPubMedCrossRef
14.
go back to reference Sener SF, Winchester DJ, Martz CH, et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer. 2001;92:748–752.PubMedCrossRef Sener SF, Winchester DJ, Martz CH, et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer. 2001;92:748–752.PubMedCrossRef
15.
go back to reference Zippel D, Siegelmann-Danieli N, Ayalon S, Kaufman B, Pfeffer R, Zvi Papa M. Delayed breast cellulitis following breast conserving operation. Eur J Surg Oncol. 2003;29:327–330.PubMedCrossRef Zippel D, Siegelmann-Danieli N, Ayalon S, Kaufman B, Pfeffer R, Zvi Papa M. Delayed breast cellulitis following breast conserving operation. Eur J Surg Oncol. 2003;29:327–330.PubMedCrossRef
16.
go back to reference Goffman TE, Laronga C, Wilson L, Elkins D. Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast J. 2004;10:405–411.PubMedCrossRef Goffman TE, Laronga C, Wilson L, Elkins D. Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast J. 2004;10:405–411.PubMedCrossRef
17.
go back to reference Senofsky GM, Moffat FL Jr, Davis K, et al. Total axillary lymphadenectomy in the management of breast cancer. Arch Surg. 1991;126:1336–41, discussion 1341–1342. Senofsky GM, Moffat FL Jr, Davis K, et al. Total axillary lymphadenectomy in the management of breast cancer. Arch Surg. 1991;126:1336–41, discussion 1341–1342.
Metadata
Title
Risk Factors Associated with Breast Lymphedema
Authors
Judy C. Boughey, MD
Tanya L. Hoskin, MS
Andrea L. Cheville, MD
Joyce Miller, RN
Margie D. Loprinzi, RN
Kristine M. Thomsen, BS
Shaun Maloney, BA
Larry M. Baddour, MD
Amy C. Degnim, MD
Publication date
01-04-2014
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 4/2014
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-013-3408-5

Other articles of this Issue 4/2014

Annals of Surgical Oncology 4/2014 Go to the issue